|
NSE Indices, the index services arm of the National Stock Exchange, has launched the Nifty500 Healthcare Index, a new sectoral benchmark designed to track the performance of healthcare-related stocks within the broader Nifty 500 universe. The index comprises the top 50 healthcare stocks based on their 6-month average free-float market capitalization. Priority is given to stocks available for trading in the derivatives segment. Each stock's weight is determined by its free-float market cap and capped at 10% to ensure diversification. The index has a base date of 1 April 2005, and a base value of 1000. It will be reconstituted semi-annually and rebalanced every quarter. As of 30 May 2025, the index delivered a 1-year total return of 20.67% and has recorded a strong 16.44% CAGR since inception. Top constituents include: Sun Pharmaceutical Industries (9.41%), Divi's Laboratories (7.70%), Max Healthcare Institute (7.67%), Cipla (7.57%) and Dr. Reddy's Laboratories (7.01%). The index is expected to serve as a benchmark for active managers and a reference for passive investment products like ETFs, index funds, and structured instruments. Powered by Capital Market - Live News
|